University of Thessaly (UTH)
Επίδραση της χορήγησης υδροξυχλωροκίνης στα ουδετερόφιλα και στην ανάπτυξη των εξωκυτταρίων παγίδων ουδετεροφίλων (Neutrophil Extracellular Traps-NETs) σε ιστούς ApoE knockout ποντικιών
Abstract
dc:descriptionIntroduction: Hydroxychloroquine (HCQ) has been associated with lower incidence of cardiovascular events and better clinical renal outcomes in patients with autoimmune diseases, while in mouse models it has been shown to reduce atherosclerosis progression and kidney damage. HCQ is a potent autophagy inhibitor, while previous data have also shown that HCQ might inhibit neutrophil extracellular traps (NETs) release. Nevertheless, the data regarding its effect in atherosclerotic plaque and kidneys are scarce. Our study aimed at investigating the effect of HCQ on autophagy and NET formation in aortas and kidneys of ApoE-/- mice. Methods: ApoE-/- mice were treated with 10mg/kg/day HCQ for 16 weeks. The aortas and kidneys were examined histologically, while immunofluorescence staining and confocal microscopy were performed to identify the co-localization of myeloperoxidase (MPO) with DNA or microtubule-associated protein 1A/1B-light chain 3B (LC3B) as markers of NET formation and autophagy, respectively. Results: Among 52 ApoE-/- mice (30 male, 22 female), HCQ was administered in 15 male and 12 female mice. HCQ was associated with a significant reduction in the mean (±SD) surface of the atherosclerotic plaque compared to controls (HCQ–treated vs. control, 0.04±0.01mm2 vs. 0.08±0.04 mm2, p<0.01 and 0.06±0.04 mm2 vs. 0.15±0.09 mm2, p=0.012, for male and female respectively). This reduction was associated with a significant attenuation in the mean fluorescence intensity of MPO and LC3B expression of the atherosclerotic plaque of HCQ treated mice (p=0.03 and p=0.01, respectively). In line with these findings, HCQ significantly reduced the proportion of MPO⁺ and LC3B⁺ cells within the atherosclerotic lesions. Renal histopathological examination of the control group showed a diffusely thick glomerular basement membrane, with concomitant mesangial hypercellularity and increased mesangial matrix in the majority of glomeruli. Fibrosis of the interstitium with minimal lymphoplasmacytic infiltrate was occasionally detected. HCQ treatment decreased the mesangial cellularity and was associated with a significant increase in corpuscle area (μm2) in male and female mice, compared to controls (HCQ males 6686± 2588 μm2 vs. control males 4614 ± 1270 μm2, p=0.035, HCQ females 5527 ± 2064 μm2 vs. control females 3815 ± 786 μm2, p=0.039). Moreover, HCQ treatment resulted in attenuation of the interstitial fibrosis and was associated with a significant increase in glomerular circularity in males (HCQ males 0.87 ± 0.31 vs. control males 0.81 ± 0.08 μm2, p=0.013) but not in female mice (HCQ females 0.88 ± 0.23 vs. control females 0.86 ± 0.02, p=0.079). These findings were associated with a significant attenuation in the mean fluorescence intensity of MPO and LC3B expression in the glomeruli of HCQ treated mice (p=0.007 and p=0.041, respectively). Discussion: HCQ administration in ApoE-/- mice may mitigate the progression of atherosclerotic plaque and improve kidney histology, by inhibiting autophagy and NET formation. A potential mechanistic explanation would be that HCQ affects lysosomal pH and thus inhibiting autophagy, which is the important “second hit” to neutrophils in order to activate their granules, decondense their chromatin and release NETs. Simultaneously, HCQ has been shown to reduce the activity of PAD4, an enzyme which is responsible for the citrullination of histones and the decondensation of DNA and the release of NETs. After the inhibition of PAD4 by HCQ, histones remain firmly adhered to chromatin not allowing their unpacking and thus the release of NETs. Hydroxychloroquine–mediated inhibition of autophagy and PAD4 may contribute to the attenuation of atherosclerotic plaque progression and renal disease among patients with chronic inflammatory diseases or cardiovascular risk factors with increased residual inflammation despite best medical treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sagris, Dimitrios
- Σαγρής, Δημήτριος
Subjects
dc:subject × 21- Αθηροσκλήρωση
- Εξωκυττάριες παγίδες ουδετεροφίλων
- Λευκοκύτταρα ουδετερόφιλα
- Υδροξυχλωροκίνη
- Νεφρική βλάβη
- Αυτοφαγία
- Neutrophil extracellular traps
- Arteriosclerosis - atherosclerosis
- Chronic renal disease
- Hydroxychloroquine
- Autophagy
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Βασική Ιατρική
- Φυσιολογία
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
- Basic Medicine
- Physiology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61517